113.68
Schlusskurs vom Vortag:
$116.30
Offen:
$112.66
24-Stunden-Volumen:
6,604
Relative Volume:
0.01
Marktkapitalisierung:
$6.45B
Einnahmen:
$738.26M
Nettoeinkommen (Verlust:
$48.89M
KGV:
131.50
EPS:
0.8645
Netto-Cashflow:
$91.69M
1W Leistung:
-3.35%
1M Leistung:
-14.95%
6M Leistung:
-9.50%
1J Leistung:
-18.47%
Repligen Corp Stock (RGEN) Company Profile
Firmenname
Repligen Corp
Sektor
Telefon
(781) 449-9560
Adresse
41 SEYON STREET, WALTHAM, MA
Compare RGEN vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
RGEN
Repligen Corp
|
114.43 | 6.44B | 738.26M | 48.89M | 91.69M | 0.8645 |
|
ISRG
Intuitive Surgical Inc
|
468.48 | 166.92B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
157.72 | 45.02B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.28 | 36.68B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
42.32 | 34.63B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
225.56 | 32.97B | 5.40B | 1.49B | 1.78B | 10.12 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | HSBC Securities | Buy |
| 2025-09-22 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-29 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Eingeleitet | Evercore ISI | In-line |
| 2025-02-10 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-04 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-03-28 | Eingeleitet | The Benchmark Company | Buy |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2021-10-14 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-23 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-11-01 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-28 | Bestätigt | First Analysis Sec | Outperform |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2019-07-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Hochstufung | CL King | Neutral → Buy |
| 2018-11-12 | Herabstufung | CL King | Buy → Neutral |
| 2018-09-26 | Eingeleitet | H.C. Wainwright | Neutral |
| 2017-12-08 | Eingeleitet | Citigroup | Buy |
| 2017-12-05 | Eingeleitet | JP Morgan | Overweight |
| 2017-11-13 | Eingeleitet | CL King | Buy |
| 2017-10-02 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Eingeleitet | William Blair | Outperform |
| 2017-02-13 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Repligen Corp Aktie (RGEN) Neueste Nachrichten
E. Ohman J or Asset Management AB Takes Position in Repligen Corporation $RGEN - MarketBeat
Repligen (RGEN) SVP R&D Ralf Kuriyel receives new stock options and RSUs - Stock Titan
Repligen (RGEN) CEO receives 25,890 options and 24,134 RSUs - Stock Titan
Repligen (NASDAQ: RGEN) COO granted options and 7,751 RSUs - Stock Titan
Repligen (RGEN) CFO awarded stock options and 7,751 restricted stock units - Stock Titan
RGEN: HC Wainwright & Co. Raises Price Target for Repligen | RGE - GuruFocus
H.C. Wainwright raises Repligen stock price target on strong growth By Investing.com - Investing.com Canada
Repligen (NASDAQ:RGEN) Price Target Raised to $208.00 - MarketBeat
Is Repligen (NASDAQ:RGEN) Influenced By Nasdaq Index Volatility? - Kalkine Media
Hudson Bay Capital Management LP Invests $2.81 Million in Repligen Corporation $RGEN - MarketBeat
Repligen Conference: CEO touts differentiated bioprocessing portfolio; CFO targets 30% EBITDA margin - Yahoo Finance
Republic Services Inc stock shines with eighth World's Most Ethical Companies honor and analyst upgr - AD HOC NEWS
Repligen Corp stock drops 3.17% on NASDAQ amid biotech sector pressures and upcoming earnings - AD HOC NEWS
Repligen Earnings Beat Puts Focus On Analytics Growth And Rich Valuation - Yahoo Finance
Alliancebernstein L.P. Buys 197,778 Shares of Repligen Corporation $RGEN - MarketBeat
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack - Yahoo Finance
270,000 Shares in Repligen Corporation $RGEN Acquired by Iron Triangle Partners LP - MarketBeat
Fred Alger Management LLC Boosts Position in Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Shares Acquired by Bamco Inc. NY - MarketBeat
Schroder Investment Management Group Purchases 254,212 Shares of Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Shares Sold by Blue Whale Capital LLP - MarketBeat
Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus
Repligen at Leerink Conference: Strategic Growth and Challenges - Investing.com
Reassessing Repligen (RGEN) Valuation After Sector Pullback And Profitability Concerns - Yahoo Finance
Evaluating Repligen (RGEN) After Sharp Share Price Declines and Conflicting Valuation Signals - Yahoo Finance
Reassessing Repligen (RGEN) Valuation After Healthcare Jobs Shock And Margin Concerns - simplywall.st
Market Moves: Whats the analyst consensus on Repligen Corporation2026 Sentiment & Expert Approved Trade Ideas - baoquankhu1.vn
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
Repligen Corporation to Present at Upcoming March Conferences - ChartMill
Bioprocessing firm Repligen fields CEO, CFO at three March investor conferences - Stock Titan
RGEN SEC FilingsRepligen 10-K, 10-Q, 8-K Forms - Stock Titan
Repligen Corporation $RGEN Shares Sold by TD Asset Management Inc - MarketBeat
NZS Capital LLC Has $26.30 Million Stake in Repligen Corporation $RGEN - MarketBeat
Repligen (RGEN) COO uses 3,911 shares to cover tax withholding - Stock Titan
Repligen (RGEN) CEO reports tax-withholding share dispositions in Form 4 - Stock Titan
Repligen (RGEN) director uses 9,897 shares to cover RSU taxes - Stock Titan
Repligen (RGEN) CFO stock withheld to cover RSU tax obligations - Stock Titan
Repligen (RGEN) SVP uses company shares to cover RSU taxes - Stock Titan
Repligen (RGEN) CPO has shares withheld to cover RSU tax bill - Stock Titan
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead - Yahoo Finance
Repligen Corporation (RGEN) Investor Outlook: Exploring a 44.7% Potential Upside in the Bioprocessing Sector - DirectorsTalk Interviews
Repligen Corporation $RGEN Position Boosted by Royce & Associates LP - MarketBeat
Artisan Partners Limited Partnership Has $28.44 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Primecap Management Co. CA Has $24.98 Million Stock Position in Repligen Corporation $RGEN - MarketBeat
Repligen (NASDAQ:RGEN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know - Yahoo Finance
Repligen Corp (RGEN) Shares Down 3.09% on Feb 27 - GuruFocus
Oversold Conditions For Repligen (RGEN) - Nasdaq
Decoding Repligen Corp (RGEN): A Strategic SWOT Insight - GuruFocus
Repligen (NASDAQ: RGEN) maps 2025 bioprocessing market, debt and control risks - Stock Titan
A Glimpse Into The Expert Outlook On Repligen Through 6 Analysts - Benzinga
Finanzdaten der Repligen Corp-Aktie (RGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Repligen Corp-Aktie (RGEN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MUIR GLENN P | Director |
Dec 16 '25 |
Option Exercise |
26.12 |
3,366 |
87,920 |
36,622 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):